Cargando…

Chromosomal changes during development and progression of prostate adenocarcinomas

Chromosomal copy number changes were investigated in 16 prostate carcinomas, 12 prostatic intraepithelial neoplasias (PIN; 4 low-grade and 8 high-grade) adjacent to the invasive tumour areas, and 5 regional lymph node metastases. For this purpose, comparative genomic hybridization (CGH) was performe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zitzelsberger, H, Engert, D, Walch, A, Kulka, U, Aubele, M, Höfler, H, Bauchinger, M, Werner, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2001
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363712/ https://www.ncbi.nlm.nih.gov/pubmed/11161378 http://dx.doi.org/10.1054/bjoc.2000.1533

Ejemplares similares

Increasing chromosome 1 copy number parallels histological progression in breast carcinogenesis
por: Cummings, M C, et al.
Publicado: (2000)

Heterogeneous Chromosomal Aberrations in Intraductal Breast Lesions Adjacent to Invasive Carcinoma
por: Aubele, Michaela, et al.
Publicado: (2000)

Chromosomal Imbalances are Associated with Metastasis-Free Survival in Breast Cancer Patients
por: Aubele, Michaela, et al.
Publicado: (2002)

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
por: Walch, Axel, et al.
Publicado: (2000)

Genetic Alterations in Presumptive Precursor Lesions of Breast Carcinomas
por: Aubele, Michaela, et al.
Publicado: (2002)

MiR-221/-222 differentiate prognostic groups in advanced breast cancers and influence cell invasion
por: Falkenberg, N, et al.
Publicado: (2013)

The impact of Cysteine-Rich Intestinal Protein 1 (CRIP1) in human breast cancer
por: Ludyga, Natalie, et al.
Publicado: (2013)

Increasing genome instability in adrenocortical carcinoma progression with involvement of chromosomes 3, 9 and X at the adenoma stage
por: Russell, A J, et al.
Publicado: (1999)

Comparing the Immunoexpression of FUT3 and FUT6 between Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
por: de Albuquerque Vasconcelos, Juliana Lúcia, et al.
Publicado: (2013)

Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
por: Harbeck, N, et al.
Publicado: (1999)

Large-scale Chromosomal Movements During Interphase Progression in Drosophila
por: Csink, Amy K., et al.
Publicado: (1998)

Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc
por: Kuhn, W, et al.
Publicado: (1999)

Nuclear Position and Shape Deformation of Chromosome 8 Territories in Pancreatic Ductal Adenocarcinoma
por: Timme, Sylvia, et al.
Publicado: (2011)

Characterization and changes of a chromosomal-scaffolding protein in human epithelia
por: Vega-Salas, Dora E., et al.
Publicado: (2002)

European randomized study of prostate cancer screening: first-year results of the Finnish trial
por: Määttänen, L, et al.
Publicado: (1999)

Switch from antagonist to agonist of the androgen receptor blocker bicalutamide is associated with prostate tumour progression in a new model system
por: Culig, Z, et al.
Publicado: (1999)

Destabilization of chromosome 9 in transitional cell carcinoma of the urinary bladder
por: Kimura, F, et al.
Publicado: (2001)

Pyruvate Kinase M1 Suppresses Development and Progression of Prostate Adenocarcinoma
por: Davidson, Shawn M., et al.
Publicado: (2022)

Heterogeneity in Breast Cancer and the Problem of Relevance of Findings
por: Aubele, M., et al.
Publicado: (1999)

Metabolic changes during prostate cancer development and progression
por: Beier, Alicia-Marie K., et al.
Publicado: (2022)

E-cadherin gene mutations are rare in adenocarcinomas of the oesophagus
por: Wijnhoven, B P L, et al.
Publicado: (1999)

No evidence of linkage to chromosome 1q42.2–43 in 131 prostate cancer families from the ACTANE Consortium
por: Singh, R
Publicado: (2000)

A role for chromosomal instability in the development of and selection for radioresistant cell variants
por: Limoli, C L, et al.
Publicado: (2001)

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk
por: Bratt, O, et al.
Publicado: (1999)

Height-related risk factors for prostate cancer
por: Norrish, A E, et al.
Publicado: (2000)

c-Ki-ras mutations in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence
por: Tang, W-Y, et al.
Publicado: (1999)

Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray
por: Bull, J H, et al.
Publicado: (2001)

Loss of chromosome 10 is an independent prognostic factor in high-grade gliomas
por: Balesaria, S, et al.
Publicado: (1999)

Comparative genomic hybridization and chromosomal instability in solid tumours
por: Rooney, P H, et al.
Publicado: (1999)

Deletion mapping of chromosome 16q in hepatocellular carcinoma
por: Piao, Z, et al.
Publicado: (1999)

Clinical usefulness of microsatellite instability for the prediction of gastric adenoma or adenocarcinoma in patients with chronic gastritis
por: Kashiwagi, K, et al.
Publicado: (2000)

The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas
por: Andersson, S, et al.
Publicado: (2001)

Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma
por: Feilotter, H E, et al.
Publicado: (1999)

Porphyrin biosynthesis in human Barrett's oesophagus and adenocarcinoma after ingestion of 5-aminolaevulinic acid
por: Hinnen, P, et al.
Publicado: (2000)

Bcl-w expression in colorectal adenocarcinoma
por: Wilson, J W, et al.
Publicado: (2000)

Loss of chromosome 11q21–23.1 and 17p and gain of chromosome 6p are independent prognostic indicators in B-cell non-Hodgkin's lymphoma
por: Stokke, T, et al.
Publicado: (2001)

Mechanisms of Physical Activity Behavior Change for Prostate Cancer Survivors: A Cluster Randomized Controlled Trial
por: Craike, Melinda J, et al.
Publicado: (2018)

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter–22q11.2
por: Hulsebos, T J M, et al.
Publicado: (1999)

Upregulation and differential expression of matrilysin (MMP-7) and metalloelastase (MMP-12) and their inhibitors TIMP-1 and TIMP-3 in Barrett's oesophageal adenocarcinoma
por: Salmela, M T, et al.
Publicado: (2001)

Allelic loss of 10q23, the PTEN tumour suppressor gene locus, in Barrett's oesophagus-associated adenocarcinoma
por: Kulke, M H, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_t81k04oqotmg78k5t6g2aaubte